U.S. FDA Overseas Staff Lacks Coordination With Agency's Centers, GAO Says
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA has no formal process for reviewing and incorporating information provided by its overseas staff into the selection of foreign drug establishments for inspection, according to the Government Accountability Office
You may also be interested in...
U.S. FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
U.S. FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama's fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes
U.S. FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
U.S. FDA would gain a boost in funding for overseas manufacturing facility inspections in President Obama's fiscal year 2012 budget, even though the agency has acknowledged its model is unsustainable and is planning changes
U.S. FDA Launches First Overseas Office in Beijing
U.S. HHS Secretary Michael Leavitt and U.S. FDA Commissioner Andrew von Eschenbach officially opened the first overseas FDA office Nov. 19 in Beijing in a continuing effort to improve foreign product safety, while the agency faces criticism from the U.S. Congress